Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1953 1
1954 4
1955 2
1956 4
1957 6
1958 2
1959 2
1960 2
1961 4
1962 6
1963 4
1964 5
1965 13
1966 12
1967 19
1968 11
1969 11
1970 18
1971 18
1972 11
1973 9
1974 8
1975 7
1976 8
1977 12
1978 8
1979 26
1980 20
1981 23
1982 17
1983 35
1984 40
1985 43
1986 53
1987 36
1988 46
1989 49
1990 47
1991 54
1992 84
1993 72
1994 74
1995 70
1996 54
1997 51
1998 84
1999 60
2000 58
2001 78
2002 62
2003 60
2004 67
2005 82
2006 77
2007 85
2008 97
2009 109
2010 119
2011 95
2012 119
2013 141
2014 112
2015 117
2016 119
2017 135
2018 117
2019 97
2020 141
2021 152
2022 104
Text availability
Article attribute
Article type
Publication date

Search Results

3,321 results
Results by year
Filters applied: . Clear all
Page 1
ST-segment elevation myocardial infarction.
Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, Steg PG, Mehran R. Vogel B, et al. Among authors: goto s. Nat Rev Dis Primers. 2019 Jun 6;5(1):39. doi: 10.1038/s41572-019-0090-3. Nat Rev Dis Primers. 2019. PMID: 31171787 Review.
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Kato ET, Silverman MG, Mosenzon O, Zelniker TA, Cahn A, Furtado RHM, Kuder J, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Bonaca MP, Ruff CT, Desai AS, Goto S, Johansson PA, Gause-Nilsson I, Johanson P, Langkilde AM, Raz I, Sabatine MS, Wiviott SD. Kato ET, et al. Among authors: goto s. Circulation. 2019 May 28;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130. Epub 2019 Mar 18. Circulation. 2019. PMID: 30882238 Clinical Trial.
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Atar D, Jukema JW, Molemans B, Taub PR, Goto S, Mach F, CerezoOlmos C, Underberg J, Keech A, Tokgözoğlu L, Bonaca MP. Atar D, et al. Among authors: goto s. Atherosclerosis. 2021 Feb;319:51-61. doi: 10.1016/j.atherosclerosis.2020.12.013. Epub 2021 Jan 18. Atherosclerosis. 2021. PMID: 33476944 Free article. Review.
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke.
Bassand JP, Apenteng PN, Atar D, Camm AJ, Cools F, Corbalan R, Fitzmaurice DA, Fox KA, Goto S, Haas S, Hacke W, Jerjes-Sanchez C, Koretsune Y, Heuzey JL, Sawhney JP, Oh S, Stępińska J, Cate VT, Verheugt FW, Kayani G, Pieper KS, Kakkar AK, Garfield-Af Investigators FT. Bassand JP, et al. Among authors: goto s. Future Cardiol. 2021 Jan;17(1):19-38. doi: 10.2217/fca-2020-0014. Epub 2020 Jul 22. Future Cardiol. 2021. PMID: 32696663
Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress.
Kitakata H, Endo J, Hashimoto S, Mizuno E, Moriyama H, Shirakawa K, Goto S, Katsumata Y, Fukuda K, Sano M. Kitakata H, et al. Among authors: goto s. Biochem Biophys Res Commun. 2021 Oct 1;572:185-190. doi: 10.1016/j.bbrc.2021.07.090. Epub 2021 Jul 30. Biochem Biophys Res Commun. 2021. PMID: 34375928 Free article.
MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H, Endo J, Matsushima H, Yamamoto S, Ikura H, Hirai A, Koh S, Ichihara G, Hiraide T, Moriyama H, Shirakawa K, Goto S, Katsumata Y, Anzai A, Kataoka M, Tokuyama T, Ishido S, Yanagi S, Fukuda K, Sano M. Kitakata H, et al. Among authors: goto s. J Mol Cell Cardiol. 2021 Dec;161:116-129. doi: 10.1016/j.yjmcc.2021.08.006. Epub 2021 Aug 12. J Mol Cell Cardiol. 2021. PMID: 34390730
3,321 results